The east Hull print works was acquired in January as part of the Clondalkin SPD deal.
It manufactures labels for the pharmaceutical, health & personal care and consumer goods end-markets.
Essentra confirmed it is entering into consultation regarding the proposed closure and transfer, with production expected to cease at the Hull site during Q4 2015 – and putting 60 jobs at risk.
Hugh Ross, Essentra managing director – Europe, said the proposal follows a comprehensive strategic review of the company’s UK activities, and entails substantial further investment at Newport.
“It is therefore with regret that we are entering a consultation regarding the possible closure of the Hull site, which is in no way a reflection on the quality or commitment of our employees. Rather, the proposed transfer of activities will help to underpin the company’s long-term position as a leading supplier to the pharmaceutical, health & personal care and consumer goods industries in the UK.”
Essentra recently posted £82m profit amidst continued synergy savings.
Source: Packaging News | Jobs | Production | Design | Innovation » News